STOCK TITAN

[Form 4] DENTSPLY SIRONA Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

GRAIL, Inc. (GRAL) – Form 144 Notice of Proposed Sale

The filing discloses that an affiliate of GRAIL intends to sell 8,000 common shares through Morgan Stanley Smith Barney LLC on or about 15 July 2025. The shares were received as Restricted Stock Units on 30 April 2025. At the stated aggregate market value of $321,440, the implied price is roughly $40.18 per share. GRAIL has 35,973,494 shares outstanding, so the sale represents less than 0.03 % of total shares.

The filer—named in a separate table as Aaron Freidin—previously sold 41,150 shares on 2 May 2025 for gross proceeds of $1,396,219.50. No additional material information, such as reasons for the sale or current company performance, is provided.

The Form 144 asserts that the seller is unaware of undisclosed material adverse information and, if relying on Rule 10b5-1, has adopted a trading plan. No earnings data or operational updates accompany the filing.

GRAIL, Inc. (GRAL) – Avviso di Proposta di Vendita ai sensi del Modulo 144

La comunicazione rivela che un affiliato di GRAIL intende vendere 8.000 azioni ordinarie tramite Morgan Stanley Smith Barney LLC intorno al 15 luglio 2025. Le azioni sono state ricevute come Restricted Stock Units il 30 aprile 2025. Al valore di mercato aggregato dichiarato di $321.440, il prezzo implicito è di circa $40,18 per azione. GRAIL ha un totale di 35.973.494 azioni in circolazione, quindi la vendita rappresenta meno dello 0,03% del totale delle azioni.

Il dichiarante — indicato in una tabella separata come Aaron Freidin — ha precedentemente venduto 41.150 azioni il 2 maggio 2025 per un ricavo lordo di $1.396.219,50. Non sono fornite ulteriori informazioni rilevanti, come motivazioni della vendita o dati sull’andamento attuale dell’azienda.

Il Modulo 144 afferma che il venditore non è a conoscenza di informazioni materiali sfavorevoli non divulgate e, nel caso si basi sulla Regola 10b5-1, ha adottato un piano di trading. Nessun dato sugli utili o aggiornamenti operativi sono allegati alla comunicazione.

GRAIL, Inc. (GRAL) – Aviso de Propuesta de Venta según el Formulario 144

La presentación revela que un afiliado de GRAIL planea vender 8,000 acciones ordinarias a través de Morgan Stanley Smith Barney LLC alrededor del 15 de julio de 2025. Las acciones fueron recibidas como Unidades de Acciones Restringidas el 30 de abril de 2025. Al valor de mercado agregado declarado de $321,440, el precio implícito es aproximadamente $40.18 por acción. GRAIL tiene 35,973,494 acciones en circulación, por lo que la venta representa menos del 0.03% del total de acciones.

El declarante — nombrado en una tabla separada como Aaron Freidin — vendió anteriormente 41,150 acciones el 2 de mayo de 2025 por ingresos brutos de $1,396,219.50. No se proporciona información adicional relevante, como motivos de la venta o desempeño actual de la empresa.

El Formulario 144 afirma que el vendedor desconoce información material adversa no divulgada y, si se basa en la Regla 10b5-1, ha adoptado un plan de negociación. No se acompañan datos de ganancias ni actualizaciones operativas.

GRAIL, Inc. (GRAL) – 제안된 매도에 관한 Form 144 공시

공시에 따르면 GRAIL의 계열사가 Morgan Stanley Smith Barney LLC를 통해 2025년 7월 15일경 8,000주 보통주를 매도할 계획입니다. 해당 주식은 2025년 4월 30일 제한 주식 단위(Restricted Stock Units)로 수령되었습니다. 총 시장가치가 $321,440로 명시되어 있으며, 주당 가격은 약 $40.18입니다. GRAIL의 총 발행 주식 수는 35,973,494주로, 이번 매도는 전체 주식의 0.03% 미만에 해당합니다.

별도의 표에 명시된 신고인 Aaron Freidin2025년 5월 2일41,150주를 매도하여 총 수익 $1,396,219.50를 올린 바 있습니다. 매도 사유나 회사의 현재 실적과 같은 추가 중요한 정보는 제공되지 않았습니다.

Form 144에는 매도자가 미공개 중대한 불리한 정보가 없음을 인지하고 있으며, Rule 10b5-1에 의거하는 경우 거래 계획을 채택했다고 명시되어 있습니다. 수익 데이터나 운영 업데이트는 포함되어 있지 않습니다.

GRAIL, Inc. (GRAL) – Avis de projet de vente selon le formulaire 144

Le dépôt révèle qu'un affilié de GRAIL prévoit de vendre 8 000 actions ordinaires via Morgan Stanley Smith Barney LLC aux alentours du 15 juillet 2025. Les actions ont été reçues sous forme de Restricted Stock Units le 30 avril 2025. À la valeur marchande totale indiquée de 321 440 $, le prix implicite est d'environ 40,18 $ par action. GRAIL compte 35 973 494 actions en circulation, la vente représentant donc moins de 0,03 % du total des actions.

Le déclarant — nommé dans un tableau séparé comme Aaron Freidin — a précédemment vendu 41 150 actions le 2 mai 2025 pour un produit brut de 1 396 219,50 $. Aucune information supplémentaire importante, telle que les raisons de la vente ou la performance actuelle de la société, n’est fournie.

Le formulaire 144 affirme que le vendeur n’a pas connaissance d’informations défavorables non divulguées et, s’il s’appuie sur la règle 10b5-1, qu’il a adopté un plan de trading. Aucun chiffre de résultat ni mise à jour opérationnelle n’accompagne le dépôt.

GRAIL, Inc. (GRAL) – Mitteilung über geplanten Verkauf gemäß Formular 144

Die Meldung gibt bekannt, dass ein verbundenes Unternehmen von GRAIL plant, 8.000 Stammaktien über Morgan Stanley Smith Barney LLC etwa am 15. Juli 2025 zu verkaufen. Die Aktien wurden als Restricted Stock Units am 30. April 2025 erhalten. Zum angegebenen Gesamtmarktwert von 321.440 $ ergibt sich ein implizierter Preis von etwa 40,18 $ pro Aktie. GRAIL hat 35.973.494 ausstehende Aktien, somit macht der Verkauf weniger als 0,03 % des Gesamtbestands aus.

Der Einreicher – in einer separaten Tabelle als Aaron Freidin genannt – verkaufte zuvor 41.150 Aktien am 2. Mai 2025 mit Bruttoerlösen von 1.396.219,50 $. Weitere wesentliche Informationen, wie Verkaufsgründe oder aktuelle Unternehmensleistung, werden nicht bereitgestellt.

Das Formular 144 erklärt, dass dem Verkäufer keine nicht offengelegten wesentlichen nachteiligen Informationen bekannt sind und dass bei Anwendung der Regel 10b5-1 ein Handelsplan eingeführt wurde. Keine Gewinnzahlen oder operative Updates sind der Meldung beigefügt.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Minor insider sale (<0.03%)—neutral impact; signals routine liquidity rather than strategic shift.

The proposed sale of 8,000 shares, worth about $0.32 million, is immaterial to GRAIL’s float and follows a larger 41,150-share sale in May. While ongoing insider selling can be construed negatively, the percentages are small and disclosed under Rule 144. No information suggests operational concerns. I view the filing as routine, with neutral-to-slightly-negative market sentiment given optics of insider sales.

TL;DR: Proper Rule 144 compliance; transparency positive, magnitude immaterial—overall neutral.

The filer provides full broker, share count, and acquisition details, indicating adherence to SEC requirements. The representation that no undisclosed adverse information exists, plus potential reliance on a 10b5-1 plan, mitigates governance concerns. Given the tiny percentage of shares, I classify the disclosure as non-impactful for corporate control or governance risk.

GRAIL, Inc. (GRAL) – Avviso di Proposta di Vendita ai sensi del Modulo 144

La comunicazione rivela che un affiliato di GRAIL intende vendere 8.000 azioni ordinarie tramite Morgan Stanley Smith Barney LLC intorno al 15 luglio 2025. Le azioni sono state ricevute come Restricted Stock Units il 30 aprile 2025. Al valore di mercato aggregato dichiarato di $321.440, il prezzo implicito è di circa $40,18 per azione. GRAIL ha un totale di 35.973.494 azioni in circolazione, quindi la vendita rappresenta meno dello 0,03% del totale delle azioni.

Il dichiarante — indicato in una tabella separata come Aaron Freidin — ha precedentemente venduto 41.150 azioni il 2 maggio 2025 per un ricavo lordo di $1.396.219,50. Non sono fornite ulteriori informazioni rilevanti, come motivazioni della vendita o dati sull’andamento attuale dell’azienda.

Il Modulo 144 afferma che il venditore non è a conoscenza di informazioni materiali sfavorevoli non divulgate e, nel caso si basi sulla Regola 10b5-1, ha adottato un piano di trading. Nessun dato sugli utili o aggiornamenti operativi sono allegati alla comunicazione.

GRAIL, Inc. (GRAL) – Aviso de Propuesta de Venta según el Formulario 144

La presentación revela que un afiliado de GRAIL planea vender 8,000 acciones ordinarias a través de Morgan Stanley Smith Barney LLC alrededor del 15 de julio de 2025. Las acciones fueron recibidas como Unidades de Acciones Restringidas el 30 de abril de 2025. Al valor de mercado agregado declarado de $321,440, el precio implícito es aproximadamente $40.18 por acción. GRAIL tiene 35,973,494 acciones en circulación, por lo que la venta representa menos del 0.03% del total de acciones.

El declarante — nombrado en una tabla separada como Aaron Freidin — vendió anteriormente 41,150 acciones el 2 de mayo de 2025 por ingresos brutos de $1,396,219.50. No se proporciona información adicional relevante, como motivos de la venta o desempeño actual de la empresa.

El Formulario 144 afirma que el vendedor desconoce información material adversa no divulgada y, si se basa en la Regla 10b5-1, ha adoptado un plan de negociación. No se acompañan datos de ganancias ni actualizaciones operativas.

GRAIL, Inc. (GRAL) – 제안된 매도에 관한 Form 144 공시

공시에 따르면 GRAIL의 계열사가 Morgan Stanley Smith Barney LLC를 통해 2025년 7월 15일경 8,000주 보통주를 매도할 계획입니다. 해당 주식은 2025년 4월 30일 제한 주식 단위(Restricted Stock Units)로 수령되었습니다. 총 시장가치가 $321,440로 명시되어 있으며, 주당 가격은 약 $40.18입니다. GRAIL의 총 발행 주식 수는 35,973,494주로, 이번 매도는 전체 주식의 0.03% 미만에 해당합니다.

별도의 표에 명시된 신고인 Aaron Freidin2025년 5월 2일41,150주를 매도하여 총 수익 $1,396,219.50를 올린 바 있습니다. 매도 사유나 회사의 현재 실적과 같은 추가 중요한 정보는 제공되지 않았습니다.

Form 144에는 매도자가 미공개 중대한 불리한 정보가 없음을 인지하고 있으며, Rule 10b5-1에 의거하는 경우 거래 계획을 채택했다고 명시되어 있습니다. 수익 데이터나 운영 업데이트는 포함되어 있지 않습니다.

GRAIL, Inc. (GRAL) – Avis de projet de vente selon le formulaire 144

Le dépôt révèle qu'un affilié de GRAIL prévoit de vendre 8 000 actions ordinaires via Morgan Stanley Smith Barney LLC aux alentours du 15 juillet 2025. Les actions ont été reçues sous forme de Restricted Stock Units le 30 avril 2025. À la valeur marchande totale indiquée de 321 440 $, le prix implicite est d'environ 40,18 $ par action. GRAIL compte 35 973 494 actions en circulation, la vente représentant donc moins de 0,03 % du total des actions.

Le déclarant — nommé dans un tableau séparé comme Aaron Freidin — a précédemment vendu 41 150 actions le 2 mai 2025 pour un produit brut de 1 396 219,50 $. Aucune information supplémentaire importante, telle que les raisons de la vente ou la performance actuelle de la société, n’est fournie.

Le formulaire 144 affirme que le vendeur n’a pas connaissance d’informations défavorables non divulguées et, s’il s’appuie sur la règle 10b5-1, qu’il a adopté un plan de trading. Aucun chiffre de résultat ni mise à jour opérationnelle n’accompagne le dépôt.

GRAIL, Inc. (GRAL) – Mitteilung über geplanten Verkauf gemäß Formular 144

Die Meldung gibt bekannt, dass ein verbundenes Unternehmen von GRAIL plant, 8.000 Stammaktien über Morgan Stanley Smith Barney LLC etwa am 15. Juli 2025 zu verkaufen. Die Aktien wurden als Restricted Stock Units am 30. April 2025 erhalten. Zum angegebenen Gesamtmarktwert von 321.440 $ ergibt sich ein implizierter Preis von etwa 40,18 $ pro Aktie. GRAIL hat 35.973.494 ausstehende Aktien, somit macht der Verkauf weniger als 0,03 % des Gesamtbestands aus.

Der Einreicher – in einer separaten Tabelle als Aaron Freidin genannt – verkaufte zuvor 41.150 Aktien am 2. Mai 2025 mit Bruttoerlösen von 1.396.219,50 $. Weitere wesentliche Informationen, wie Verkaufsgründe oder aktuelle Unternehmensleistung, werden nicht bereitgestellt.

Das Formular 144 erklärt, dass dem Verkäufer keine nicht offengelegten wesentlichen nachteiligen Informationen bekannt sind und dass bei Anwendung der Regel 10b5-1 ein Handelsplan eingeführt wurde. Keine Gewinnzahlen oder operative Updates sind der Meldung beigefügt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
HOLDEN BETSY D

(Last) (First) (Middle)
C/O DENTSPLY SIRONA INC
13320-B BALLANTYNE CORPORATE PLACE

(Street)
CHARLOTTE NC 28277

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
07/11/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/11/2025 A 502.594(1) A $0 53,255.959 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.
Remarks:
Exhibit 24 - Power of Attorney
/s/ Jessica Causey, Attorney-in-Fact for Betsy D. Holden 07/15/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Dentsply Sirona Inc

NASDAQ:XRAY

XRAY Rankings

XRAY Latest News

XRAY Latest SEC Filings

XRAY Stock Data

3.30B
198.48M
0.45%
106.2%
4.05%
Medical Instruments & Supplies
Dental Equipment & Supplies
Link
United States
CHARLOTTE